🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
50.78
-0.68 (-1.32%)
At close: Nov 20, 2026, 4:00 PM EST
52.48
+1.70 (3.35%)
After-hours: Nov 20, 2026, 7:38 PM EST

Cytokinetics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-777.89-784.96-589.53-526.24-388.96-215.31
Depreciation & Amortization
13.5210.139.5311.895.812.28
Loss (Gain) From Sale of Assets
--0.05---
Asset Writedown & Restructuring Costs
-----2.84
Loss (Gain) From Sale of Investments
-0.19-0.03-0.020.040.11-
Stock-Based Compensation
131.33112.2997.8472.0747.8526.83
Other Operating Activities
91.35188.1950.5824.8360.3732.38
Change in Accounts Receivable
-32.08-1.11-15.37-1.1456.67-47.4
Change in Accounts Payable
6.432.66-4.48-3.484.521.06
Change in Unearned Revenue
0.04-50.7652.37--87-
Change in Other Net Operating Assets
10.6313.583.147.711.154.8
Operating Cash Flow
-571.97-510.01-395.89-414.33-299.52-142.52
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-16.61-24.81-3.91-1.42-11.34-48.87
Investment in Securities
-348.1641.47-549.19240.67-250.8-98.91
Investing Cash Flow
-364.7716.67-553.1239.25-262.13-147.78

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-729.46--523.59-
Long-Term Debt Repaid
--413.51-9.62-0.86-188.93-
Net Debt Issued (Repaid)
-15.96315.95-9.62-0.86334.66-
Issuance of Common Stock
836.5535.98759.86182.6917.54324.85
Repurchase of Common Stock
-4.46-2.47-19.63-10.52-9.6-4.87
Other Financing Activities
10017520050173.56-
Financing Cash Flow
916.13524.46930.61221.32516.17319.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.45-0.720.21-0.02--
Net Cash Flow
-22.0530.4-18.1746.22-45.4829.68

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-588.58-534.82-399.8-415.75-310.85-191.39
Free Cash Flow Growth
------
Free Cash Flow Margin
-519.53%-607.48%-2164.10%-5521.23%-328.64%-271.76%
Free Cash Flow Per Share
-4.55-4.45-3.57-4.31-3.46-2.49
Levered Free Cash Flow
-403.33-379.62-241.29-260.37-127.01-179.83
Unlevered Free Cash Flow
-317.71-314.7-187.22-224.33-95.04-161.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
15.5922.9125.9710.315.179.18
Change in Working Capital
-30.09-35.6335.663.09-24.78.46
SEC Filings: 10-K · 10-Q